- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
|Compound class||Peptide or derivative|
|International Nonproprietary Names|
|BMN 111 | BMN-111|
|Vosoritide is an investigational peptide analogue of C-type natriuretic peptide (CNP) with a longer half-life (duration of action) than the endogenous peptide . It comprises the 37 C-terminal amino acids from human CNP with the addition of proline and glycine (PG) at its N-terminal.
Vosoritide represents a novel mechanism which has the potential to treat fibroblast growth factor receptor 3-driven achondroplasia .
|GtoPdb PubChem SID||315661153|
|Search PubMed clinical trials||vosoritide|
|Search PubMed titles||vosoritide|
|Search PubMed titles/abstracts||vosoritide|